2025 Congress Posters

Posters will be displayed in the Poster Gallery, located in the exhibition and catering area, in static A0 portrait format from Monday to Wednesday of the Congress.

A dedicated Poster Session will take place on Monday, 1 September, from 12:15 to 12:55, and will include guided poster tours.

Click on a poster title to view its abstract.

 

CONSUMER INVOLVEMENT

 
POSTER # POSTER TITLE PRESENTING AUTHOR
01 PATIENT NEEDS AND PRIORITIES FOR A GOAL-SETTING INTERVENTION IN KIDNEY TRANSPLANT RECIPIENTS: A WORKSHOP REPORT Chandana Guha
 

ENVIRONMENTAL SUSTAINABILITY AND GREEN NEPHROLOGY

 
02 EXPLORING THE ASSOCIATED IMPACTS OF AMBIENT HEAT AND HEATWAVES ON CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS. Dale Coghlan
03 COMPARISON OF ANNUAL RESOURCE USAGE AND WASTE PRODUCTION FROM DISINFECTION OF FOUR COMMONLY USED HAEMODIALYSIS MACHINES IN AUSTRALIA Jane Waugh
04 COMPARISON OF WASTE GENERATED BY FOUR HAEMODIALYSIS MACHINES COMMONLY USED IN AUSTRALIA Jane Waugh
 

EXPERIMENTAL TUBULOINTERSTITIAL DISEASE

 
05 EMPAGLIFLOZIN MITIGATES RENAL INTERSTITIAL FIBROSIS BY TARGETING INFLAMMATION AND FIBROBLAST ACTIVATION IN FABRY DISEASE So Young Lee

GENERAL NEPHROLOGY – ACUTE KIDNEY INJURY

06 FALSE ALARMS: MULTIFOCAL RENAL LESIONS HIDING A BENIGN REALITY Angela Au
07 THE DOMINO EFFECT: VLCAD DEFICIENCY TRIGGERING RHABDOMYOLYSIS AND RENAL FAILURE Angela Au
08 ROCK AND A HARD PLACE: ACUTE PHOSPHATE NEPHROPATHY IN A PATIENT TREATED FOR HYPOPHOSPHATAEMIA Angela Au
09 THE ROLE OF PLASMA EXCHANGE IN SHIGA-TOXIN-RELATED HAEMOLYTIC URAEMIC SYNDROME Zena Barakat
10 SPOTTING THE ZEBRAS: A RARE ADULT CASE OF SHIGA TOXIN-PRODUCING ESCHERICHIA COLI-MEDIATED HAEMOLYTIC URAEMIC SYNDROME Lucy Birtwistle
11 ACUTE KIDNEY INJURY OF A PATIENT WITH CANCER: IMPACT OF CANCER THERAPIES ON NEPHROTOXICITY OR OLD-FASHIONED CAUSE OF ACUTE KIDNEY INJURY Elaine Cheng
12 METASTATIC PROSTATE CANCER ASSOCIATED THROMBOTIC MICROANGIOPATHY AND ACUTE KIDNEY INJURY Alice Dolan
13 COMPARISON OF CLINICAL OUTCOMES FOLLOWING ACUTE KIDNEY INJURY IN PATIENTS AGED 65–79 VERSUS 80 YEARS AND OLDER AT A SINGLE TERTIARY METROPOLITAN CENTRE Arunima Jain
14 BILATERAL RENAL INFARCTION COMPLICATING PAGETT-SCHROETTER DISEASE IN A PATIENT WITH PATENT FORAMEN OVALE Peter-Joon Lee
15 A CASE OF SEVERE LEPTOSPIROSIS-RELATED RHABDOMYOLYSIS Lucy Marshall
16 ELTROMBOPAG-ASSOCIATED ANTIPHOSPHOLIPID SYNDROME (APS) AND THROMBOTIC MICROANGIOPATHY (TMA) WITH CARDIAC AND RENAL INVOLVEMENT IN A PATIENT WITH IMMUNE THROMBOCYTOPENIA (ITP) Khalil Patankar
17 SHROOM FOR CONCERN: A CASE OF PSYCHEDELIC MUSHROOM-INDUCED ACUTE KIDNEY INJURY Nasir Shah
18 DISCHARGE DOCUMENTATION OF RESTARTING CARDIO-KIDNEY-METABOLIC MEDICATIONS IN GENERAL MEDICAL PATIENTS WITH AN ACUTE KIDNEY INJURY: AN OBSERVATIONAL STUDY Wayne Thai
19 GEMCITABINE ASSOCIATED THROMBOTIC MICOANGIOPATHY WITH OLIGOANURIC ACUTE KIDNEY INJURY Rivindu Wijayaratne
20 PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA PRESENTING AS ANURIC RENAL FAILURE. Pamela Wu

GENERAL NEPHROLOGY – DIABETES/CARDIOVASCULAR/HYPERTENSION

21 RARE CAUSE OF SECONDARY HYPERTENSION: CASE REPORT Sneha Amin
22 RENOPROTECTIVE EFFECTS OF HUMAN BONE MARROW MESENCHYMAL STEM CELL-DERIVED EXOSOMES VIA YAP1 MODULATION IN KIDNEY FIBROSIS Qinrui Chen
23 THE IMPORTANCE OF SCREENING FOR SECONDARY HYPERTENSION CAUSES IN YOUNG ADULTS Madeleine Cosgrave
24 AUDIT OF SAFETY OF METFORMIN IN STAGE 5 CHRONIC KIDNEY DISEASE (CKD) Eimer McMullan
25 A NOVEL ANIMAL MODEL OF CARDIORENAL SYNDROME Wenyang Shi

GENERAL NEPHROLOGY – EPIDEMIOLOGY AND PUBLIC HEALTH

26 EPIDEMIOLOGY OF RARE KIDNEY DISEASES: A SCOPING REVIEW Neeru Agarwal
27 WILLINGNESS OF PSYCHOLOGICAL TREATMENTS AND SERVICE NEEDS IN DIALYSIS PATIENTS: A SINGLE-CENTRE SURVEY Ramony Chan
28 FILTER YOUR FUTURE: HEALTHY KIDNEYS EDUCATION PROJECT Ashton Kline
29 PREVALENCE OF LONELINESS AND SOCIAL ISOLATION IN PATIENTS RECEIVING KIDNEY REPLACEMENT THERAPY Amanda Sluiter

GENERAL NEPHROLOGY – GLOMERULONEPHRITIS

30 A MASQUERADING DIAGNOSIS, CLL AND C3GN: A CASE REPORT Sneha Amin
31 HEPATITIS B AND SYPHILIS CO-INFECTION PRESENTING WITH HEPATITIS AND MEMBRANOUS NEPHROPATHY IN A YOUNG ADULT Laura Bywater
32 INITIAL RESULTS OF THE APAXAN TRIAL: A PROSPECTIVE, OPEN-LABEL, RANDOMIZED CONTROLLED TRIAL ON PHARMACOKINETICS OF HIGHLY PROTEIN BOUND DIRECT ORAL ANTICOAGULANT (APIXABAN) IN PREVENTION AND TREATMENT OF PRIMARY NEPHROTIC SYNDROME ASSOCIATED THROMBOEMBOLIC DISEASE. Shaun Chandler
33 MANAGEMENT CHALLENGES IN INDEX PRESENTATION OF ANURIC RENAL FAILURE SECONDARY TO MIXED ANCA VASCULITIS AND ANTI-GBM DISEASE Christine Chang
34 VALIDATION OF ANCA VASCULITIS PROGNOSTICATION TOOLS IN QUEENSLAND COHORT Yi Zhi Cheong
35 CASE REPORT: RITUXIMAB USE FOR REFRACTORY ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE IN A TRANSGENDER PATIENT Amy Chew
36 PLA2R ANTIBODY NEGATIVE MEMBRANOUS NEPHROPATHY IN THE SETTING OF MULTIPLE SCLEROSIS, SUCCESSFULLY TREATED WITH OCRELIZUMAB: A CASE REPORT Cynthia Chhoa
37 MANAGEMENT AND CLINICAL OUTCOMES OF PATIENTS DIAGNOSED WITH FIBRILLARY GLOMERULONEPHRITIS – A REGIONAL CASE SERIES Joshua Choo
38 IGG4-RELATED DISEASE: A CASE REPORT HIGHLIGHTING DIAGNOSTIC CHALLENGES AND THERAPEUTIC RESPONSES Rachel Frederick
39 A COSTING STUDY OF IGAN AND C3G KIDNEY DISEASES WITHIN AUSTRALIAN HOSPITALS: IMPLICATIONS UNDER THE ACTIVITY-BASED FUNDING FRAMEWORK Tessa Gastrell
40 EXPANDING INDICATIONS FOR RITUXIMAB IN GLOMERULAR DISEASE – A SINGLE-CENTRE RETROSPECTIVE CASE SERIES Breanna Hollow
41 PATTERNS OF BIOPSY-CONFIRMED GLOMERULONEPHRITIS IN WESTERN AUSTRALIA – A SINGLE-CENTRE PREVALENCE ANALYSIS Breanna Hollow
42 ATYPICAL CASE OF C3-DOMINANT CRESCENTIC GLOMERULONEPHRITIS: A DIAGNOSTIC CHALLENGE BETWEEN C3 GLOMERULOPATHY AND INFECTION-RELATED GN Isra Iftikhar
43 AVACOPAN-ASSOCIATED THROMBOCYTOPENIA IN MPO-ANCA ASSOCIATED VASCULITIS: A CASE SERIES Isra Iftikhar
44 USTEKINUMAB INDUCED IGA NEPHROPATHY Vinothkumar Kavarthapol Jayaraman
45 CASE REPORT: IMMUNE COMPLEX MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS WITH C3 AND IGG DOMINANT IMMUNOHISTOCHEMISTRY STAINING ASSOCIATED WITH SERONEGATIVE MYASTHENIA GRAVIS Aimee Khoo
46 THE ESTABLISHMENT OF THE AUSTRALIA AND NEW ZEALAND VASCULITIS QUALITY AND DISEASE REGISTRY (ANZVASC-QDR): FRAMEWORK AND PROTOCOLS A. Richard Kitching
47 RELAPSE OF MYELOPEROXIDASE ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS POST RENAL TRANSPLANT: A CASE OF REFRACTORY PULMONARY DISEASE DESPITE IMMUNOSUPPRESSION Karissa La Burniy
48 A RARE CASE OF PARANEOPLASTIC VASCULITIS Ting chia Lew
49 A NEPHROTIC MASQUERADE: A CASE OF IGA NEPHROPATHY WITH MINIMAL CHANGE VARIANT Tracy Li
50 SOME LIKE IT HOT: THERMAL AMPLITUDE AND THE DIAGNOSIS OF CRYOGLOBULINAEMIC VASCULITIS Alli Madden
51 SADDLE PULMONARY EMBOLUS AS A PRESENTING MANIFESTATION OF MEMBRANOUS LUPUS NEPHRITIS Julien Nithianandan
52 A CASE OF WALDENSTROM MACROGLOBULINEMIA PRESENTING WITH MINIMAL CHANGE DISEASE Jessica Oon
53 EARLY AUSTRALIAN EXPERIENCE OF AVACOPAN USE IN ANCA-ASSOCIATED VASCULITIS: A CASE SERIES Eoin O’Sullivan
54 UNVEILING GLOMERULONEPHRITIS IN THE PACIFIC: A FIJIAN COHORT STUDY Angus Ritchie
55 REAL WORLD MANAGEMENT OF IG A NEPHROPATHY: A SINGLE CENTRE EXPERIENCE Jessica Ryan
56 LUPUS PODOCYTOPATHY – NEW ENTITY WITH ADDED COMPLEXITY Victoria Sasongko
57 UNCOVERING THE PATIENT JOURNEY: THE LIVED EXPERIENCE AND PSYCHOSOCIAL IMPACT OF IGA NEPHROPATHY IN AUSTRALIA. Jessica Sun
58 UNCOVERING THE PATIENT JOURNEY: THE LIVED EXPERIENCE AND PSYCHOSOCIAL IMPACT OF C3 GLOMERULOPATHY IN AUSTRALIA. Jessica Sun
59 A CASE OF LUPUS NEPHRITIS WITH SEVERE AKI IN A PATIENT WITH PRIMARY BILIARY CIRRHOSIS, WHERE RENAL FUNCTION IMPROVED AND WAS MAINTAINED WITH MMF AND STEROIDS. Kazuhiro Takeuchi
60 SUSTAINED REMISSION WITH ECULIZUMAB IN REFRACTORY LUPUS NEPHRITIS WITH ATYPICAL HAEMOLYTIC URAEMIC SYNDROME Brady Thomson
61 COMPLETE REMISSION WITH RITUXIMAB IN RELAPSED PRIMARY FOCAL SEGMENTAL GLOMERULOSCLEROSIS WITHOUT USE OF HIGH-DOSE GLUCOCORTICOIDS Brady Thomson
62 ADALIMUMAB INDUCED SARCOIDOSIS-LIKE REACTION PRESENTING AS AN OMENTAL MASS AND RENAL FAILURE. Amanda Varghese
63  RENAL CHRONIC GRAFT-VERSUS-HOST DISEASE IN AN ALLOGENIC HAEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENT. Gabriella Wong

GENERAL NEPHROLOGY – OTHER

64 NIP THE ITCH TWICE, NOT THRICE: BIWEEKLY DIFELIKEFALIN IN TREATING PRURITUS ASSOCIATED WITH CHRONIC KIDNEY DISEASE IN HAEMODIALYSIS PATIENTS Lucy Birtwistle
65 LUPUS NEPHRITIS OR AUTONOMIC GANGLIONOPATHY WITH CLASS V LUPUS NEPHRITIS; DIVIDED IN DIAGNOSIS, UNIFIED IN TREATMENT. Rajeewa Dassanayake
66 COMPLETE RECOVERY OF THROMBOTIC MICROANGIOPATHY WITH SEVERE ACUTE KIDNEY INJURY DUE TO INTRAVENOUS USE OF MODIFIED RELEASE OXYCODONE. Moses Ezeakile
67 DEVELOPMENT OF DMX-200 (REPAGERMANIUM), A CCR2 INHIBITOR, FOR FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS) David Fuller
68 SEVERE HYPOPHOSPHATEMIA AFTER FERRIC CARBOXYMALTOSE INFUSION – THE RISK BENEATH THE COMMON PRACTICE Ting chia Lew
69 A PURPURIC PREDICAMENT: IGA VASCULITIS IN END STAGE KIDNEY DISEASE Danial M Mahmood
70 A PYELONEPHRITIS PLOT TWIST: HYPERMUCOVISCOUS KLEBSIELLA PNEUMONIAE CAUSING RENAL ARTERY MYCOTIC ANEURYSM AND DISSEMINATED SEPSIS Lucy Mcmullen
71 NATIVE KIDNEY BIOPSY OUTCOMES AT A REGIONAL AUSTRALIAN CENTRE: FOUR-YEAR AUDIT FROM GOULBURN VALLEY HEALTH Kadison Michel
72 TWISTS AND STONES: A CASE REPORT Johnathan Ngo
73 ECULIZUMAB FOR THE TREATMENT OF THROMBOTIC MICROANGIOPATHY SECONDARY TO METASTATIC PROSTATE CANCER Steven Thien Nguyen
74 PRECLINICAL EVALUATION AND PRELIMINARY RESULTS FROM THE PHASE 1A CLINICAL TRIAL OF PYC-003 FOR THE TREATMENT OF PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) Anja Stirnweiss
75 KIDNEY AND INFERIOR VENA CAVA ABNORMALITIES WITH LEG THROMBOSES Limy Wong

GENERAL NEPHROLOGY – PREGNANCY ASSOCIATED

76 CASE REPORT – NEPHROTIC SYNDROME IN PREGNANCY WITH SPONTAENOUS RESOLUTION POST-PARTUM Neha Chandrasekar
77 MATERNAL AND NEONATAL OUTCOMES IN WOMEN RECEIVING HOME BASED DIALYSIS MODALITY (HOME HAEMODIALYSIS AND PERITONEAL DIALYSIS): AN ANALYSIS OF THE ANZDATA REGISTRY Shilpa Jesudason
78 WHEN BIOPSY IS NOT AN OPTION: NAVIGATING PERIPARTUM NEPHROTIC SYNDROME WITH PULMONARY EMBOLISM Takuma Konno
79 POSTPARTUM DIAGNOSIS OF COARCTATION OF THE AORTA AS A SECONDARY CAUSE OF HYPERTENSION UNMASKED BY PRE-ECLAMPSIA Julien Nithianandan

GENETICS

80 ATYPICAL KIDNEY DISEASE IN A FAMILY WITH TUBEROUS SCLEROSIS COMPLEX Julia Donald
81 ATP6V1B1 HETEROZYGOUS VARIANTS INVOLVING THE R394 RESIDUE CAUSE AUTOSOMAL DOMINANT DISTAL RENAL TUBULAR ACIDOSIS Thomas Forbes
82 UTILITY OF PHARMACOGENETICS IN MEDICATION OPTIMISATION FOR PATIENTS WITH CHRONIC KIDNEY DISEASE Ashley Irish
83 ASSESSMENT OF THE CAUSAL RELATIONSHIP BETWEEN MITOCHONDRIAL FUNCTION AND INFLAMMATION USING INDUCED PLURIPOTENT STEM CELLS DERIVED FROM PATIENTS WITH CHRONIC GLOMERULONEPHRITIS Akira MimaIMA
84 TUBEROUS SCLEROSIS: AN AUDIT OF CARE PROVISION IN AN AUSTRALIAN TERTIARY CENTRE Steven Thien Nguyen
85 FROM ELBOW PAIN TO GENETIC DIAGNOSIS: FOCAL SEGMENTAL GLOMERULOSCLEROSIS IN THE CONTEXT OF NAIL-PATELLA SYNDROME Julien Nithianandan

HAEMODIALYSIS – CKD-MBD/ANAEMIA/ADEQUACY

86 NOT ALL THAT LYTIC IS MALIGNANT: LESSONS FROM DISSEMINATED BROWN TUMOURS Angela Au
87 TRANSLATING PIVOTAL INTO PRACTICE: SIX-MONTH OUTCOMES OF A NURSE-LED PROACTIVE IRON PROTOCOL IN HAEMODIALYSIS Rachel Elliott
88 AN AUDIT OF ADVERSE CLINICAL OUTCOMES, ASSOCIATED RISK FACTORS AND MANAGEMENT IN INTERMITTENT HAEMODIALYSIS PATIENTS AT A TERTIARY REFERRAL CENTRE Samantha Giang
89 A SINGLE CENTRE OUTCOME ANALYSIS OF PROACTIVE INTRAVENOUS IRON THERAPY IN HAEMODIALYSIS PATIENTS, BASED ON PIVOTAL TRIAL, VERSES HISTORICAL REACTIVE INTRAVENOUS IRON SUPPLEMENTATION Amanda Leong
90 SUCCESSFUL TREATMENT OF REFRACTORY TUMOURAL CALCINOSIS IN A DIALYSIS PATIENT WITH INTRAVENOUS SODIUM THIOSULFATE Archee Singh

HAEMODIALYSIS – OTHER

91 IMPACT OF TRAVEL TIME TO DIALYSIS AND SITE PREFERENCE: A SURVEY OF HAEMODIALYSIS PATIENTS AT WESTERN HEALTH Liana Candiloro
92 GUIDELINE-DIRECTED MEDICAL THERAPY FOR HEART FAILURE WITH REDUCED EJECTION FRACTION IN PATIENTS ON MAINTENANCE HAEMODIALYSIS Julian Daniell
93 ASSESSING THE PREVALENCE, SEVERITY, AND IMPACT OF DIALYSIS-ASSOCIATED PRURITUS (DAP) IN WESTERN AUSTRALIAN HAEMODIALYSIS PATIENTS AND ITS IMPACTS ON QUALITY OF LIFE Ethan Driver
94 A CASE OF SEVERE, RECURRENT ANAPHYLAXIS DURING HAEMODIALYSIS SUCCESSFULLY TREATED DESPITE UNKNOWN TRIGGERS Jessie Madden
95 ASSESSING FUNCTIONAL CAPACITY IN HEMODIALYSIS AND HEMODIAFILTRATION PATIENTS USING THE 30-SECOND CHAIR TO STAND TEST: A CROSS-SECTIONAL STUDY IN ANGELES CITY, PAMPANGA, PHILIPPINES Angelie Lorraine Pesebre
96 A CASE REPORT OF PENICILLIN DESENSITIZATION AND PROLONGED INFUSION THERAPY FOR THE TREATMENT OF STREPTOCOCCUS MITIS GROUP BACTERAEMIA IN AN INTERMITTENT HAEMODIALYSIS PATIENT WITH A HISTORY OF BETA-LACTAM ANAPHYLAXIS Thomas Robinson
97 HYPERKALAEMIA AFTER ILEOSTOMY IN A HAEMODIALYSIS PATIENT Isabella Shue
98 AN ATYPICAL PRESENTATION OF CALCIPHYLAXIS Phoebe Tin
99 GETTING TO THE GUTS OF IT: EVALUATING FACTORS THAT INFLUENCE VACCINE HYPO-RESPONSIVENESS IN PATIENTS RECEIVING MAINTENANCE HAEMODIALYSIS Erin Vaughan

HAEMODIALYSIS – VASCULAR ACCESS

100 ANALYSIS OF ATERIOVENOUS FISTULA PATENCY RATES: A RETROSPECTIVE COHORT STUDY Sharon Chen
101 COMPLICATIONS OF BRACHIOCEPHALIC STENOSIS SECONDARY TO EXTRINSIC COMPRESSION WITH HYPERDYNAMIC ARTERIOVENOUS FISTULA IN A HAEMODIALYSIS DEPENDENT PATIENT Joy Hong
102 EVALUATION OF KIDNEY FAILURE RISK EQUATION SCORE FOR VASCULAR ACCESS PLANNING IN AN AUSTRALIAN COHORT Regina Hong
103 TOWARD ZERO DEATHS DUE TO DIALYSIS VASCULAR ACCESS HAEMORRHAGE: INVIDIVUAL UNIT RESPONSES Evelyn Perry
104 MIXED METHODS VALIDATION STUDY OF A STANDARDISED CLINICAL VASCULAR ACCESS ASSESSMENT TOOL Rizza Antoinette Yap So
105 VASCULAR ACCESS OUTCOMES IN A COHORT OF HAEMODIALYSIS PATIENTS UNDERGOING ROUTINE CLINICAL EXAMINATION Rizza Antoinette Yap So

INTERVENTIONAL NEPHROLOGY

106 SCALPEL OR CATHETER? – A SINGLE-CENTRE STUDY OF ENDOVASCULAR VS. SURGICAL AVF CREATION Johnathan Ngo
107 VEIN OR VAIN? A CASE REPORT Johnathan Ngo
108 FIRST ENDO-AVFS: A PROSPECTIVE SINGLE-CENTRE EXPERIENCE Johnathan Ngo
109 ADJUNCT INTERVENTIONS AFTER ENDO-AVF CREATION – “ONE-AND-DONE” REALISTIC? Johnathan Ngo
110 MAPPING SUCCESS: A SINGLE-CENTRE AUDIT OF PATIENT FACTORS AND ENDO-AVF SUITABILITY Johnathan Ngo
111 ILIAC ARTERY DISSECTION AS AN OVERLOOKED CAUSE OF POST-RENAL TRANSPLANT HYPERTENSION: A CASE REPORT Himanshu Pendse

KIDNEY SUPPORTIVE CARE

112 MANAGING INTRACTABLE CHRONIC KIDNEY DISEASE ASSOCIATED PRURITUS: A CASE REPORT OF DIFELIKEFALIN USE IN A NON-DIALYSIS PATIENT Elizabeth Josland
113 EVALUATING ELECTRONIC ADVANCED CARE PLANS IN ADMISSIONS UNDER RENAL MEDICINE Rebecca Teng Jing Yap

NUTRITION

114 A K-RITICAL REVIEW: THE SAFETY OF POTASSIUM INTAKE IN CHRONIC KIDNEY DISEASE  – A SYSTEMATIC REVIEW AND SYNTHESIS WITHOUT META-ANALYSIS (SWIM) Rui Du
115 DIETARY PATTERNS OF PEOPLE WITH GENETIC KIDNEY DISEASE (THE DIET-GKD STUDY):PRELIMINARY FINDINGS Kelly Lambert

OTHER

116 NEPHRONEXUS: A RESEARCHER’S ROADMAP TO PUBLIC DATA IN NEPHROLOGY Eoin O’Sullivan

PAEDIATRICS

117 RAVULIZUMAB IN TREATMENT RESISTANT PAEDIATRIC IGA NEPHROPATHY – A CASE REPORT Julia Donald

PERITONEAL DIALYSIS

118 PANTOE IN PERITONEAL DIALYSIS: A RARE CAUSE OF PERITONEAL DIALYSIS PERITONITIS Sivakajani Balakumar
119 DIALYSIS ADEQUACY ASSESSMENT IN PERITONEAL DIALYSIS: A SURVEY OF CURRENT PRACTICE IN AUSTRALIA AND NEW ZEALAND Aruni Malaweera
120 PERITONEAL DIALYSIS-ASSOCIATED PERITONITIS CAUSED BY ENTEROCOCCUS GALLINARUM TREATED WITH INTRAPERITONEAL TEICOPLANIN Julien Nithianandan
121 THE SUCCESSFUL USE OF TAUROLOCK FOR BIOFILM ERADICATION AND PD CATHETER SALVAGE IN A PATIENT WITH RELAPSING PD-ASSOCIATED PERITONITIS Jack Rycen
122 REAL WORLD EXIT SITE CARE AND RISK OF INFECTION IN PERITONEAL DIALYSIS PATIENTS AT WESTERN RENAL SERVICES Jadon Ryan Yang
123 BARRIERS TO COMPLIANCE WITH EXIT SITE CARE AT WESTERN RENAL SERVICES Jadon Ryan Yang

QUALITY INDICATORS AND IMPROVEMENT

124 THE SMARTER STONES SOLUTION: A NEW DIETITIAN-LED KIDNEY STONE MODEL OF CARE Briar Bennett
125 ENHANCING CLINICAL CARE FOR RURAL AND REMOTE AUSTRALIANS WITH A RARE KIDNEY DISEASE: CYSTINURIA Jessica Fraser
126 GENETIC TEST FIELDS IN AUSTRALIA AND NEW ZEALAND DIALYSIS AND TRANSPLANT REGISTRY – WHAT/WHEN/WHO AND THE FUTURE Sadia Jahan
127  ALLOPURINOL DOSING AND SERUM URATE CONCENTRATIONS IN PATIENTS WITH GOUT ON DIALYSIS: A RETROSPECTIVE CHART REVIEW Noha Kamel
128 PREDICT, PLAN, PREVENT: A DATA-DRIVEN QUALITY IMPROVEMENT APPROACH TO DIALYSIS ACCESS Eoin O’Sullivan

TRANSPLANTATION

129 COLONIC MALAKOPLAKIA IN A RENAL TRANSPLANT RECIPIENT: A RARE INTERSECTION OF OPPORTUNISTIC INFECTION AND GRANULOMATOUS INFLAMMATION Sivakajani Balakumar
130 A CASE OF PROSTHETIC MATERIAL MYCOBACTERIUM FORTUITUM INFECTIVE ENDOCARDITIS IN A RENAL TRANSPLANT RECIPIENT Sharon Chen
131 DISSEMINATED HISTOPLASMOSIS IN A LONG TERM AUSTRALIAN RENAL TRANSPLANT RECIPIENT Aleksandra Djordjevic
132 PNEUMOCYSTIS JIROVECII PNEUMONIA PRESENTING WITH REFRACTORY HYPERCALCAEMIA IN AN IMMUNOSUPPRESSED RENAL TRANSPLANT RECIPIENT Evelyn Perry
133 SUCCESSFUL TRANSPLANTATION OF HEPATITIS B VIREMIC DONOR (NAT+) TO TWO HEPATITIS B IMMUNE PATIENTS Katherine Richards
134 TRANSPLANT RENAL VEIN STENOSIS – A RARE CAUSE OF KIDNEY ALLOGRAFT DYSFUNCTION Jack Rycen
135 CYSTIC OVARIAN DISEASE AS A MANIFESTATION OF MYCOBACTERIUM AVIUM COMPLEX IN A PATIENT WITH FAILING GRAFT Victoria Sasongko
136 NIRMALTREVIR/RITONAVIR AND TACROLIMUS DRUG INTERACTION IN A TRANSPLANT PATIENT Victoria Sasongko

 

Categories